Carl Dambkowski, Chief Officer, has filed 0 purchases and 60 sales on the open market. Over the past 12 months that comes to a net sale of $17.3M. The latest trade was on 06/22.

CD

CD

Carl Dambkowski

Chief Medical Officer

First filing

23/12/20

Trades

96 trades

Buys / sales

0 / 60

12-month net buying

−$17.3M

Last trade

06/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AT Apogee Therapeutics	Open-market sale10b5-1 plan	06/22	06/24	26,400 sh	$132.60	$3,500,640	−12.8%
Oruka TherapeuticsORKA	Open-market sale10b5-1 plan	06/11–06/12	06/12	35,000 sh2 trades	$70.12avg.	$2,454,298.34	−47.5%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	06/03	06/05	5,500 sh	$78.71	$432,905	−2.6%
Oruka TherapeuticsORKA	Open-market sale10b5-1 plan	05/21	05/22	105,000 sh3 trades	$58.97avg.	$6,191,341.39	−58.7%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	05/06	05/08	5,500 sh2 trades	$84.14avg.	$462,784	−2.6%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	04/01	04/03	5,500 sh3 trades	$84.84avg.	$466,619.04	−2.6%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	03/04	03/06	5,500 sh3 trades	$71.06avg.	$390,824.75	−2.6%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	02/04	02/04	5,500 sh5 trades	$65.79avg.	$361,860.03	−2.5%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	01/07	01/09	18,700 sh4 trades	$77.84avg.	$1,455,613.06	−8.1%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/12/04	25/12/05	10,900 sh	$75.00	$817,500	−3.9%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/11/05	25/11/07	10,785 sh4 trades	$55.07avg.	$593,902.84	−3.7%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/10/01	25/10/03	5,110 sh	$39.80	$203,378	−1.8%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/09/03	25/09/05	2,725 sh2 trades	$37.87avg.	$103,198.2	−1.2%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/08/06	25/08/08	2,725 sh	$37.78	$102,950.5	−1.1%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/07/02	25/07/03	10,090 sh3 trades	$45.09avg.	$454,954.04	−4.1%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/06/04	25/06/06	2,725 sh	$36.96	$100,716	−1.1%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/05/07	25/05/09	2,725 sh	$35.75	$97,418.75	−1.1%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/04/02	25/04/04	3,860 sh3 trades	$36.22avg.	$139,801.27	−1.5%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/03/05	25/03/07	1,590 sh	$30.48	$48,463.2	−0.6%
AT Apogee Therapeutics	Open-market sale10b5-1 plan	25/02/05	25/02/07	3,520 sh	$40.69	$143,228.8	−1.4%